Golden Biotechnology (Taiwan) Probability of Future Stock Price Finishing Under 15.36
| 4132 Stock | TWD 16.55 0.45 2.65% |
Golden |
Golden Biotechnology Target Price Odds to finish below 15.36
The tendency of Golden Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to NT$ 15.36 or more in 90 days |
| 16.55 | 90 days | 15.36 | roughly 2.62 |
Based on a normal probability distribution, the odds of Golden Biotechnology to drop to NT$ 15.36 or more in 90 days from now is roughly 2.62 (This Golden Biotechnology probability density function shows the probability of Golden Stock to fall within a particular range of prices over 90 days) . Probability of Golden Biotechnology price to stay between NT$ 15.36 and its current price of NT$16.55 at the end of the 90-day period is about 11.09 .
Assuming the 90 days trading horizon Golden Biotechnology has a beta of -0.15. This suggests as returns on the benchmark increase, returns on holding Golden Biotechnology are expected to decrease at a much lower rate. During a bear market, however, Golden Biotechnology is likely to outperform the market. Additionally Golden Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Golden Biotechnology Price Density |
| Price |
Predictive Modules for Golden Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Golden Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Golden Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Golden Biotechnology is not an exception. The market had few large corrections towards the Golden Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Golden Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Golden Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | -0.15 | |
σ | Overall volatility | 1.41 | |
Ir | Information ratio | -0.12 |
Golden Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Golden Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Golden Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Golden Biotechnology generated a negative expected return over the last 90 days | |
| Golden Biotechnology has high historical volatility and very poor performance | |
| The company reported the revenue of 78.35 M. Net Loss for the year was (336.49 M) with profit before overhead, payroll, taxes, and interest of 51.31 M. | |
| Golden Biotechnology has accumulated about 152.56 M in cash with (306.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33. |
Golden Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Golden Stock often depends not only on the future outlook of the current and potential Golden Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Golden Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Average Daily Volume Last 10 Day | 182.54k | |
| Average Daily Volume In Three Month | 377.72k |
Golden Biotechnology Technical Analysis
Golden Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Golden Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Golden Biotechnology. In general, you should focus on analyzing Golden Stock price patterns and their correlations with different microeconomic environments and drivers.
Golden Biotechnology Predictive Forecast Models
Golden Biotechnology's time-series forecasting models is one of many Golden Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Golden Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Golden Biotechnology
Checking the ongoing alerts about Golden Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Golden Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Golden Biotechnology generated a negative expected return over the last 90 days | |
| Golden Biotechnology has high historical volatility and very poor performance | |
| The company reported the revenue of 78.35 M. Net Loss for the year was (336.49 M) with profit before overhead, payroll, taxes, and interest of 51.31 M. | |
| Golden Biotechnology has accumulated about 152.56 M in cash with (306.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33. |
Additional Tools for Golden Stock Analysis
When running Golden Biotechnology's price analysis, check to measure Golden Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Golden Biotechnology is operating at the current time. Most of Golden Biotechnology's value examination focuses on studying past and present price action to predict the probability of Golden Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Golden Biotechnology's price. Additionally, you may evaluate how the addition of Golden Biotechnology to your portfolios can decrease your overall portfolio volatility.